Skip to main content
Year archive

JOHNSON PHARMACARE LIMITED — 2026 filings

All 35 regulatory filings released by JOHNSON PHARMACARE LIMITED (532154) in 2026, sourced directly from the official regulator.

35 Filings
2026 Period
2026 filings (35)
Filing Released Lang
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To consider and approve ....
Regulatory Filings
2026-05-22 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2026-05-09 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-30 English
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015
Regulatory Filings
2026-04-17 English
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment of mr. Dheeraj ....
Regulatory Filings
2026-04-17 English
1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The Board has appointed ....
Regulatory Filings
2026-04-17 English
Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026
Regulatory Filings
2026-04-13 English
Intimation of Closure of Trading Window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 for the Quarter and Year Ended on 31st March 2026.
Regulatory Filings
2026-03-21 English
Disclosure as per Regulation 30 of SEBI LODR Regualtion 2015 for the appointment of Additional Non- Executive & Independent Director.
Regulatory Filings
2026-02-17 English
Disclosure as per Regulation 30 of SEBI LODR Regulation 2015 for the appointment of Statutory Auditor.
Regulatory Filings
2026-02-17 English
Revised outcome of Meeting of Board of Directors held on Friday 13th Feburay 2026 at Pursuant to Regulation 30 of SEBI LODR Regulation 2015.
Regulatory Filings
2026-02-17 English
Submission of Extract of Newspaper Publication of Unaudited (Standalone) Financials Results for the quarter ended on 31st December 2025
Regulatory Filings
2026-02-16 English
Undertaking for Non- applicability of reg 32 of sebi (lodr) regualtion 2015 for the quarter ended on 31st December 2025
Regulatory Filings
2026-02-14 English
Submission of unaudited (Stanalone) Financials results of (Johnson Pharmacare Limited) for the quarter ended on 31st December 2025 along with limited Review Report Thereon.
Regulatory Filings
2026-02-14 English
UNAUDITED (STANDALONE) FINANCIAL RESULTS The Board of Director have considered and approved the Unaudited (Standalone) Financial Results along with Limited Review Report thereon for the ....
Regulatory Filings
2026-02-14 English
Disclosure as per Regulation 30 of SEBI (LODR) Regulations 2015 Appointment of Parul Agrawal as Additional (Non-Executive Independent Director) of the company.
Regulatory Filings
2026-02-13 English
Disclosure under Regulation 30 of SEBI (LODR) regarding appointmrent of M/S VRSK & Associates as Statutory Auditors of the Company .
Regulatory Filings
2026-02-13 English
1. The Board of Director have considered and approved the appointment of M/S. VRSK & Associates (FRN:011199N) as Statutory Auditor of the Company to fill the casual vacancy w.e.f. 13.02.2026. ....
Regulatory Filings
2026-02-13 English
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve With reference to our intimation ....
Regulatory Filings
2026-02-12 English
Disclosure as per Regulation 30 of SEBI (LODR) Regulations, 2015 Appointment of Mr. Umesh kumar as an Additional Executive Director of the company.
Regulatory Filings
2026-02-09 English
The Board has appointed Mr. Umesh Kumar (DIN: 07015921) as an Additional Executive Director of the Company w.e.f 09th February, 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/201
Regulatory Filings
2026-02-09 English
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve To consider and approve ....
Regulatory Filings
2026-02-05 English
Disclosure of Change of Corporate Office Pursuant to Regualtion 30 of the SEBI (LODR) Regulations 2015
Regulatory Filings
2026-02-02 English
The board has considered and approve the removal of the Corporate Office ' 1002 10th Floor, Vikram Tower, Rajendra Place, New Delhi-110060., Rajender Nagar, Central Delhi, New Delhi, ....
Regulatory Filings
2026-02-02 English
Board Approved the appointment of Babita as an Non Executive & Independent Director w.e.f. 31st January 2026.
Regulatory Filings
2026-01-31 English
Board Approved the Resignation of Mr. Umesh Kumar (DIN: 07015921) as an Additional & Executive Director
Regulatory Filings
2026-01-31 English
The Board has appointed Ms. Babita (DIN: 09064124) as a Non-Executive & Independent Director of the Company w.e.f 31st January, 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/201
Regulatory Filings
2026-01-31 English
Pursuant to Regulation 30 of SEBI (LODR) Regulation 2025 there is change in directors of board MS. Babita (DIN: 09064124) Non Executive & Independent Director of the Company has reisgned ....
Regulatory Filings
2026-01-24 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Board approved the appointment of Mr. Rajendra Prasad (DIN: 10871533) as an Additional & Non-Executive Director of the Company ....
Regulatory Filings
2026-01-24 English
1. The Board has appointed Mr. Rajender Parsad (DIN: 10871533) as an Additional & Non- Executive Director of the Company w.e.f 24rd January, 2026 a brief profile pursuant to SEBI Circular ....
Regulatory Filings
2026-01-24 English
Disclosure as per Regulation 30 of SEBI(LODR) Regulation 2015
Regulatory Filings
2026-01-21 English
Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirement) regarding Resignation of M/S Rishi Sekhri and Associates Chartered Accountant (126656) as Statutory ....
Regulatory Filings
2026-01-15 English
Certificate under Regulation 74(5) of SEBI (Depositories & Participants ) Regulations, 2018.
Regulatory Filings
2026-01-13 English
Disclosure As Per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015.
Regulatory Filings
2026-01-08 English
Pursuant to the provisions of Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting ....
Regulatory Filings
2026-01-08 English